Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 942438-89-3 | MDL No. : | MFCD04972386 |
Formula : | C6H7BClNO3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | LOLPLMDQLOJSDH-UHFFFAOYSA-N |
M.W : | 187.39 | Pubchem ID : | 24901777 |
Synonyms : |
|
Num. heavy atoms : | 12 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.17 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 4.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 45.56 |
TPSA : | 62.58 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.95 cm/s |
Log Po/w (iLOGP) : | 0.0 |
Log Po/w (XLOGP3) : | 0.69 |
Log Po/w (WLOGP) : | -0.58 |
Log Po/w (MLOGP) : | -0.57 |
Log Po/w (SILICOS-IT) : | -0.55 |
Consensus Log Po/w : | -0.2 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.67 |
Solubility : | 3.96 mg/ml ; 0.0212 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.58 |
Solubility : | 4.91 mg/ml ; 0.0262 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -1.66 |
Solubility : | 4.09 mg/ml ; 0.0218 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.2 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P280-P305+P351+P338-P310 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H332-H335 | Packing Group: | N/A |
GHS Pictogram: |
![]() |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
<strong>[26621-44-3]3-nitro-1H-pyrazole</strong> (145 mg, 1.28 mmol, 1.2 eq), copper (II) chloride (14.4 mg, 0.11 mmol, 0.1 eq), DBU (199 muL, 1.33 mmol, 1.25 eq), and ethanol (5.0 mL) were combined and stirred for 5 minutes. (5-chloro-6-methoxypyridin-3-yl)boronic acid (200 mg, 1.07 mmol, 1.0 eq) was added, air was bubbled through the reaction, and the mixture was heated to 60 C for 5 days. The mixture was filtered through celite, and the filtrate evaporated. The crude residue was dissolved in dichlormethane and washed with 2N NaOH, saturated aqueous NH4Cl, water, and brine. The organic layer was collected and evaporated to provide 3-chloro-2-methoxy-5-(3-nitro-1H-pyrazol-1-yl)pyridine, the full quantity of which was carried forward in the following step without further manipulation. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With tripotassium phosphate tribasic; dichloro(1,1'-bis(diphenylphosphanyl)ferrocene)palladium(II) dichloromethane adduct; In N,N-dimethyl-formamide; at 60℃; for 3h;Inert atmosphere; Sealed tube; | A mixture of <strong>[6627-22-1]methyl 6-chloropyrimidine-4-carboxylate</strong> (100 mg, 0.579 mmol), (5-chloro-6- methoxypyridin-3-yl)boronic acid (217 mg, 1.16 mmol), dichloro[1,1'-bis(diphenylphos- 10 phino)ferrocene]palladium dichloromethane adduct (42 mg, 0.058 mmol) and potassium phosphate (369 mg, 1.74 mmol) in DMF (5 mL) was purged with argon and heated in a sealed tube at 60 C for 3 h. After this time, the reaction mixture was concentrated under reduced pressure, and the residue obtained was purified by FCC (Silica, 40-80% EtOAc in DCM) to give the title compound.1H NMR (300 MHz, DMSO-d6) δ 9.40 (d, J = 1.5 Hz, 1H), 9.09 (d, J = 2.1 Hz, 1H), 8.77 (d, J = 2.1 Hz, 1H), 15 8.64 (d, J = 1.2 Hz, 1H), 4.05 (s, 3H), 3.96 (s, 3H). | |
With tripotassium phosphate tribasic; dichloro(1,1'-bis(diphenylphosphanyl)ferrocene)palladium(II) dichloromethane adduct; In N,N-dimethyl-formamide; at 60℃; for 3h;Inert atmosphere; Sealed tube; | A mixture of <strong>[6627-22-1]methyl 6-chloropyrimidine-4-carboxylate</strong> (100 mg, 0.579 mmol), (5-chloro-6- methoxypyridin-3-yl)boronic acid (217 mg, 1.16 mmol), dichloro[1,1'-bis(diphenylphos- 10 phino)ferrocene]palladium dichloromethane adduct (42 mg, 0.058 mmol) and potassium phosphate (369 mg, 1.74 mmol) in DMF (5 mL) was purged with argon and heated in a sealed tube at 60 C for 3 h. After this time, the reaction mixture was concentrated under reduced pressure, and the residue obtained was purified by FCC (Silica, 40-80% EtOAc in DCM) to give the title compound.1H NMR (300 MHz, DMSO-d6) δ 9.40 (d, J = 1.5 Hz, 1H), 9.09 (d, J = 2.1 Hz, 1H), 8.77 (d, J = 2.1 Hz, 1H), 15 8.64 (d, J = 1.2 Hz, 1H), 4.05 (s, 3H), 3.96 (s, 3H). |